Combination Therapy with Lumacaftor-Ivacaftor in Cystic Fibrosis Keeping It Real

被引：3

作者：

Sala, Marc A. ^{[1
]}

Jain, Manu ^{[1
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Chicago, IL 60611 USA

来源：

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷 / 02期

关键词：

PHE508DEL CFTR; MUTATION; EFFICACY; SAFETY;

D O I：

10.1164/rccm.201910-1894ED

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：133 / 134

页数：3

共 50 条

[1] Adherence to lumacaftor-ivacaftor therapy in patients with cystic fibrosis in France
Olivereau, Lucie
Nave, Viviane
Garcia, Stephan
Perceval, Marie
Rabilloud, Muriel
Durieu, Isabelle
Reynaud, Quitterie
[J]. JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (03) : 402 - 406
[2] Combination lumacaftor and ivacaftor therapy for cystic fibrosis
McColley, Susanna A.
[J]. EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (02): : 233 - 242
[3] REAL WORLD EXPERIENCE OF LUMACAFTOR-IVACAFTOR AT AN URBAN CYSTIC FIBROSIS CENTER
Ahmad, D.
Patel, M.
Mills, N.
Stephen, M. J.
[J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 205 - 205
[4] Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy
Connett, G. J.
[J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2405 - 2412
[5] Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis
Burgel, Pierre-Regis
Munck, Anne
Durieu, Isabelle
Chiron, Raphael
Mely, Laurent
Prevotat, Anne
Murris-Espin, Marlene
Porzio, Michele
Abely, Michel
Reix, Philippe
Marguet, Christophe
Macey, Julie
Sermet-Gaudelus, Isabelle
Corvol, Harriet
Bui, Stephanie
Lemonnier, Lydie
Dehillotte, Clemence
Da Silva, Jennifer
Paillasseur, Jean-Louis
Hubert, Dominique
Mounard, Julie
Poulet, Claire
Rames, Cinthia
Person, Christine
Troussier, Francoise
Urban, Thierry
Dalphin, Marie-Laure
Dalphin, Jean-Claude
Pernet, Didier
Richaud-Thiriez, Benedicte
Fayon, Mickael
Macey-Caro, Julie
Campbell, Karine
Laurans, Muriel
Borderon, Corinne
Heraud, Marie-Christine
Labbe, Andre
Montcouquiol, Sylvie
Bassinet, Laurence
Remus, Natascha
Fanton, Annlyse
Houzel-Charavel, Anne
Huet, Frederic
Perez-Martin, Stephanie
Boldron-Ghaddar, Amale
Scalbert, Manuela
Camara, Boubou
Llerena, Catherine
Pin, Isabelle
Quetant, Sebastien
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (02) : 188 - 197
[6] Real World Assessment of Patients with Cystic Fibrosis Treated with Lumacaftor-Ivacaftor and Transitioned to Tezacaftor-Ivacaftor
Christmas, A.
O'Hagan, A. R.
Morton, R. L.
Eid, N. S.
Bickel, S. G.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[7] Continuous glucose monitoring in youth with cystic fibrosis treated with lumacaftor-ivacaftor
Li, Angel
Vigers, Tim
Pyle, Laura
Zemanick, Edith
Nadeau, Kristen
Sagel, Scott D.
Chan, Christine L.
[J]. JOURNAL OF CYSTIC FIBROSIS, 2019, 18 (01) : 144 - 149
[8] Real World Respiratory Effectiveness of Lumacaftor-Ivacaftor in Children with Cystic Fibrosis at Four Nemours Cystic Fibrosis Centers
Greenawald, L.
Shenoy, A. R.
Peeke, K.
Elidemir, O.
Livingston, F. R.
Schaeffer, D. A.
Chidekel, A. S.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[9] EFFECTS OF LUMACAFTOR-IVACAFTOR (ORKAMBI) AFTER 6 MONTHS OF THERAPY IN CHILDREN WITH CYSTIC FIBROSIS
Nayak, V. H.
Bouso, J.
Makris, C.
Burns, J. J.
Elidemir, O.
[J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S301 - S301
[10] SAFETY AND REAL WORLD NUTRITIONAL EFFECTIVENESS OF LUMACAFTOR-IVACAFTOR IN CHILDREN WITH CYSTIC FIBROSIS AT FOUR NEMOURS CYSTIC FIBROSIS CENTERS
Greenawald, L.
Shenoy, A.
Peeke, K.
Elidemir, O.
Livingston, F.
Schaeffer, D.
Chidekel, A.
[J]. PEDIATRIC PULMONOLOGY, 2017, 52 : S318 - S318

← 1 2 3 4 5 →